Abbonarsi

Small bowel capsule endoscopy in obscure gastrointestinal bleeding: A matched cohort comparison of patients with normal vs surgically altered gastric anatomy - 20/08/22

Doi : 10.1016/j.clinre.2022.101921 
Xavier Dray a, , Gabriel Rahmi b, Maria Elena Riccioni c, Geoffroy Vanbiervliet d, Gabriele Wurm Johansson e, Chloé Leandri f, Peter Baltes g, Clotilde Duburque h, Franck Cholet i, Anastasios Koulaouzidis j, k, l, m, Lucille Quénéhervé i
on behalf of the

I-CARE group and the PREPINTEST study group

a Sorbonne University, Centre for Digestive Endoscopy, Saint Antoine Hospital, APHP, Paris, France 
b Hôpital Européen Georges Pompidou. Department of Gastroenterology, Paris, France 
c Fondazione Policlinico A.Gemelli-IRCCS, Roma, Italy 
d Gastroenterology, CHU, Hôpital L´Archet 2, Gastroenterology, Nice, France 
e Skåne University Hospital, Lund University, Department of Gastroenterology, Malmö, Sweden 
f Cochin University Hospital, Gastroenterology, Paris, France 
g Agaplesion Bethesda Krankenhaus Bergedorf, Klinik für Innere Medizin, Hamburg, Germany 
h Saint Philibert, Lomme, France 
i Brest University Hospital, Hepatogastroenterology unit, Brest, France 
j Department of Medicine, Odense University Hospital (OUH), Svendborg Sygehus, Svendborg, Denmark 
k Department of Clinical Research, University of Southern Denmark (SDU), Odense, Denmark 
l Surgical Research Unit, OUH, Odense, Denmark 
m Department of Social Medicine and Public Health, Pomeranian Medical University, Szczecin, Poland 

Corresponding author.

Highlights

What is already known on this subject?Small bowel capsule endoscopy (CE) is feasible in most patients with surgically-altered gastric anatomy (SAGA) and obscure gastrointestinal bleeding.
What are the new findings?Orally ingested SBCE in patients with SAGA have a longer small bowel transit time, a lower completion rate but a similar diagnostic yield, with significantly more frequent inflammatory/ulcerated lesions, as compared to non-operated patients paired on age, gender and overt vs obscure of bleeding.
How might it impact on clinical practice in the foreseeable future?First, oral ingestion should be considered in most patients with SAGA when SBCE is indicated for OGIB, whereas indications for endoscopic delivery of CE should be limited. Second, different preparation modalities (possibly with the use of boosters), may be considered in patients with SAGA.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background

Little is known about small bowel capsule endoscopy (SBCE) outcomes in patients with surgically altered anatomy.

Aims

To assess the feasibility and diagnostic yield of orally ingested SBCE to investigate obscure gastrointestinal bleeding (OGIB) in patients with surgically altered gastric anatomy, compared to native gastric anatomy.

Methods

207 patients with OGIB were selected from an open, multicenter, retrospective cohort (SAGA study) and match-paired according to age, gender and bleeding type (overt/occult) to 207 control patients from a randomized controlled trial (PREPINTEST). Primary outcomes were the diagnostic yield (P1 or P2 findings), completion rate, adverse events rate, and small bowel transit time (SBTT).

Results

The diagnostic yield was not statistically different between groups (44.9% in SAGA vs 42.5% in control patients). Inflammatory/ulcerated lesions were significantly more frequent in patients with SAGA (43.0% vs 29.3%). The median SBTT was significantly longer in the SAGA group than in control patients (283 vs 206 minutes), with a significantly lower completion rate (82.6% vs 89.9%); Adverse events were scarce (0.5% vs 0.0%).

Conclusion

Patients with surgically altered gastric anatomy should benefit from SBCE investigation for OGIB as much as non-operated patients.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Capsule endoscopy, Gastrectomy, Gastrointesintal bleeding, Small bowel bleeding


Mappa


© 2022  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 46 - N° 7

Articolo 101921- Agosto 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Changhai advanced endoscopy courses for ERCP (CHANCE) training program: A short-term training model in China
  • Di Zhang, Dan Wang, Tian-Jiao Wang, Ren-Pei Wu, Lu Hao, Ya-Wei Bi, Hong-Lei Guo, Xiang-Peng Zeng, Yu Liu, Teng Wang, Lin He, Huai-Yu Yang, Dong Wang, Zhen-Dong Jin, Duo-Wu Zou, Zhuan Liao, Yi-Qi Du, Luo-Wei Wang, Xin-Gang Shi, Jie Chen, Kai-Xuan Wang, Yu Bai, Lei Xin, Liang-Hao Hu, Zhao-Shen Li, Chinese Society of Digestive Endoscopy, China Endoscopists Association
| Articolo seguente Articolo seguente
  • Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study
  • Qin Shi, Feihang Wang, Nan Du, Yongjie Zhou, Xin Zhou, Jingqin Ma, Minjie Yang, Zihan Zhang, Jiaze Yu, Wen Zhang, Jianjun Luo, Lingxiao Liu, Zhiping Yan

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.